Unique ID issued by UMIN | UMIN000026964 |
---|---|
Receipt number | R000030841 |
Scientific Title | Evaluation of background lung disease as risk factors of the drug-related interstitial pneumonia induced by the lung cancer chemotherapy |
Date of disclosure of the study information | 2017/04/15 |
Last modified on | 2020/04/14 14:50:42 |
Evaluation of background lung disease as risk factors of the drug-related interstitial pneumonia induced by the lung cancer chemotherapy
Risk factors of drug-related interstitial pneumonia by the lung cancer chemotherapy
Evaluation of background lung disease as risk factors of the drug-related interstitial pneumonia induced by the lung cancer chemotherapy
Risk factors of drug-related interstitial pneumonia by the lung cancer chemotherapy
Japan |
Lung cancer, Interstitial pneumonia
Pneumology |
Malignancy
NO
Verification of better evaluation method of interstitial shadow complicated with primary lung cancer, and the validity of the chemotherapy, using the past information of the study subject
Others
We decided to use HRCT fibrosis score (HFS) applied to idiopathic pulmonary fibrosis (IPF), and Goddard Classification about pulmonary emphysema in addition. We perform the analysis of the CT image by Lung Vision (image analysis software). By these, we verify the evaluation method of the patient of lung cancer complicated with interstitial pneumonia in the background lungs and verify the validity of chemotherapy.
Confirmatory
Pragmatic
Not applicable
Difference of the frequency of the chemotherapy induced aggravation of interstitial pneumonia between patients with interstitial shadow and without the shadow.
Frequency of the interstitial shadow in lung cancer patients performed chemotherapy, prognostic difference between with or without interstitial shadow, rate of concordance in observers about an evaluation of the interstitial shadow, rate of concordance of conventional HRCT score, Goddard classification and the evaluation in Lung Vision
Others,meta-analysis etc
Not applicable |
Not applicable |
Male and Female
Lung cancer patients performed chemotherapy in study entry facilities during from April 1, 2013 to March 31, 2016.
Refusal by the notices to the Internet, patients that the later information was not provided by changing hospital enough, in addition, patients whom researchers judged to be inappropriate as a study subject.
1000
1st name | Hiroshi |
Middle name | |
Last name | Mukae |
Nagasaki University Hospital
Second Department of Internal Medicine
852-8501
1-7-1 Sakamoto, Nagasaki city, Nagasaki prefecture, Japan
095-819-7273
hmukae@nagasaki-u.ac.jp
1st name | Hiroshi |
Middle name | |
Last name | Gyotoku |
Nagasaki University Hospital
Second Department of Internal Medicine
852-8501
1-7-1 Sakamoto, Nagasaki-city, Nagasaki, Japan
095-819-7273
gyotoku-h@umin.ac.jp
Nagasaki University Hospital, Second Department of Internal Medicine
Nagasaki University Hospital, Second Department of Internal Medicine
Other
Japan
Nagasaki University Hospital
1-7-1 Sakamoto, Nagasaki-city, Nagasaki, Japan
095-819-7726
gaibushikin@ml.nagasaki-u.ac.jp
NO
2017 | Year | 04 | Month | 15 | Day |
Published
214
Completed
2017 | Year | 04 | Month | 15 | Day |
2017 | Year | 03 | Month | 28 | Day |
2017 | Year | 04 | Month | 15 | Day |
2021 | Year | 04 | Month | 14 | Day |
We accumulate the data backward by cooperative groups
2017 | Year | 04 | Month | 12 | Day |
2020 | Year | 04 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030841
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |